Activation of TAp73 and Inhibition of TrxR for Improved Cancer Therapy in TP53 Mutant Pancreatic Tumors

Future Science OA - United Kingdom
doi 10.4155/fsoa-2018-0082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors

Clinical Cancer Research
Cancer ResearchOncology
2013English

Tp53 Mutant Zebrafish Develop Malignant Peripheral Nerve Sheath Tumors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Improved Cancer Pain Management After Radiation Therapy for Painful Tumors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Gene Therapy for Pancreatic Cancer

English

Multidisciplinary Therapy for Pancreatic Cancer.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1996English

Vaccine and Cancer Therapy for Genitourinary Tumors

2012English

Inhibition of Group 1 P21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation and Increases Survival of Mice With Pancreatic Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Gene Therapy of Pancreatic Cancer

Journal of Genetic Syndromes & Gene Therapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy